Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices
Wei Zhou, Xiaoyi Qin, Xiang Hu, Yingru Lu, Jingye Pan
Abstract
Background: Corona Virus Disease 2019 (COVID-19) has become a global pandemic. This study established prognostic scoring models based on comorbidities and other clinical information for severe and critical patients with COVID-19. Material and Methods: We retrospectively collected data from 51 patients diagnosed as severe or critical COVID-19 who were admitted between January 29, 2020, and February 18, 2020. The Charlson (CCI), Elixhauser (ECI), and age-and smoking-adjusted Charlson (ASCCI) and Elixhauser (ASECI) comorbidity indices were used to evaluate the patient outcomes.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Charlson comorbidity indexComorbidityInternal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMultivariate analysisCritical illnessCritically illEmergency medicineDiseasePathologyOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsCOVID-19 diagnosis using AI